A Deep Dive Into MoCRA

A Deep Dive Into MoCRA – FDA Watch

In this episode, Shelly and Wayne chat with Will Woodlee, Managing Partner at Kleinfeld, Kaplan & Becker, LLP, and David Lennarz, President of Registrar Corp. You'll hear their thoughts on the top priorities in cosmetics regulation for the next FDA Commissioner and their insights on all things MoCRA, including how it intersects with ingredient transparency and the clean beauty movement, how the modernized framework might be enforced, and its overall impact on businesses, consumers, and industry. In our headlines segment, Shelly and Wayne delve into these major developments: Pharma: Commissioner Califf Reflects on COVID-19 Devices: AdvaMed Praises Congressional AI Task Force Food: FDA Amends Color Additive Regulations for FD&C Red No. 3 Cosmetics: PCPC Webinar Focuses on Sustainability In our Resource Links segment, we listed key documents in our four core areas. To view these links, subscribe, or find out more information about our podcast, visit FDAWatch.net. Want to be a sponsor, marketing partner, or guest, or provide feedback on the podcast? Email us at info@fdawatch.net. Music by Dvir Silver from Pixabay.

Listen on Spotify

Listen on Apple Podcasts

In this episode, Shelly and Wayne chat with Will Woodlee, Managing Partner at Kleinfeld, Kaplan & Becker, LLP, and David Lennarz, President of Registrar Corp. You’ll hear their thoughts on the top priorities in cosmetics regulation for the next FDA Commissioner and their insights on all things MoCRA, including how it intersects with ingredient transparency and the clean beauty movement, how the modernized framework might be enforced, and its overall impact on businesses, consumers, and industry.

Headlines

Pharma: Commissioner Califf Reflects on COVID-19

Devices: AdvaMed Praises Congressional AI Task Force

Food: FDA Amends Color Additive Regulations for FD&C Red No. 3

Cosmetics: PCPC Webinar Focuses on Sustainability

Resource Links

Pharma: 

Devices: FDA’s new guidance oFDA issues draft guidance on marketing submissions for AI-enabled medical devicesn AI in drug development centers the risk introduced by the technology

Food: FDA Proposes Requiring At-a-Glance Nutrition Information on the Front of Packaged Foods

Cosmetics: Registrar Corp: 135,000 imported cosmetics products still non-compliant with MoCRA

About Our Guests

Will Woodlee

Will Woodlee is a Managing Partner at the Washington, D.C., law firm of Kleinfeld, Kaplan & Becker, LLP. He has a broad practice in the food, drug, and cosmetic, fields.

David Lennarz

David Lennarz is the President at Registrar Corp. He manages the company’s overseas operations. He has worked for almost 22 years in FDA-regulated industries in the U.S. and Europe.